Alzheimers Disease and other Cognitive Disorders
Resources
Basic Information
Introduction & Causes of Cognitive DisordersDementiaAlzheimer's DiseaseOther Cognitive DisordersDementia Coping Skills & Behavior ManagementTraumatic Brain Injury (TBI)Conclusion and Resources
More InformationLatest News
An ALS Drug Shows Early Promise Against Alzheimer'sAHA News: Dementia Can Complicate Heart Recovery and TreatmentDeaths From Alzheimer's Far More Common in Rural AmericaCould COVID-19 Accelerate Alzheimer's Symptoms?Dementia Cases Will Nearly Triple Worldwide by 2050: StudyFDA Panel Advisor Who Panned New Alzheimer's Drug Speaks Out'Light Flash' Treatment Might Help Slow Alzheimer'sCleaning Up the Air Could Help Prevent Alzheimer'sLong-Term Outlook for Most With Serious Brain Injury Is Better Than ThoughtDrug Shows Promise in Easing Dementia-Linked PsychosisAHA News: Diabetes and Dementia Risk: Another Good Reason to Keep Blood Sugar in Check1 in 20 Cases of Dementia Occurs in People Under 65Could Menopausal Hormone Therapy Reduce Women's Odds for Dementia?Reading, Puzzles May Delay Alzheimer's by 5 Years: StudyTwo Major Health Systems Won't Administer Controversial New Alzheimer's DrugMost Marriages Survive a Spouse's Brain InjuryMedicare Mulls Coverage for Controversial Alzheimer's DrugFDA Head Asks for Investigation Into Alzheimer's Drug ApprovalNew Prescribing Instructions Tighten Use of Controversial Alzheimer's DrugMissing Teeth, Higher Odds for Dementia?AHA News: Smoking Harms the Brain, Raises Dementia Risk – But Not If You QuitHealthy Living Can Lower Your Odds for Alzheimer'sKeeping Same Nurse for All Home Health Care May Be Crucial for Dementia PatientsMost Cases of Dementia in U.S. Seniors Go Undiagnosed: StudyLilly to Seek FDA Approval for New Alzheimer's DrugCould a Type of Statin Raise Dementia Risks?Good News, Bad News From Alzheimer's Vaccine TrialPoor Sleep After Head Injury Could Point to Dementia RiskFDA Approves Alzheimer's Drug Despite Expert Panel's ObjectionsFDA Defends Approval of Controversial Alzheimer's DrugPeople of Color Have Twice the Risk of Dying After Brain Injury, Study FindsIn People With Type 1 Diabetes, Poor Blood Sugar Control Could Raise Dementia RiskThere's Been a Shift in Who's Funding Alzheimer's ResearchHealthy Living Helps Prevent Dementia, Even If It Runs in the FamilyAHA News: Is It Normal Aging or Early Signs of Dementia?Dementia Risk Rises as Years Lived With Type 2 Diabetes IncreasesHead Injury, Alzheimer's Appear to Affect Brain in Similar WaysBrain Injuries Raise Long-Term Risk of StrokeResearch Shows Links Between Gum Disease and Alzheimer'sAssisted Living Centers Can Do More for Dementia Patients, Experts Say6 Steps to Reduce Caregiver StressLoneliness in Mid-Life Linked to Higher Odds for Alzheimer'sDrug Used in Cancer Patients Might Help Treat Alzheimer's'Non-Drug' Approaches Can Fight Depression in People With DementiaSuicide Attempts Spike Soon After Dementia DiagnosisCould a New Drug Help Ease Alzheimer's?AHA News: Dementia May Be a Risk Factor for Infection But Not Death From COVID-19Your Eyes May Signal Your Risk for Stroke, DementiaEven 1 Concussion May Raise Your Odds for Dementia LaterAlzheimer's Patients Are Being Given Too Many Meds
Questions and AnswersVideosLinksBook Reviews
Related Topics

Aging & Geriatrics
Memory Problems
Elder Care

Could Menopausal Hormone Therapy Reduce Women's Odds for Dementia?

HealthDay News
by By Ernie Mundell and Robert Preidt HealthDay Reporters
Updated: Jul 20th 2021

new article illustration

TUESDAY, July 20, 2021 (HealthDay News) -- Women on hormone replacement therapy (HRT) for menopause go on to have a 58% lower risk of Alzheimer's disease and other neurodegenerative conditions, a new study finds.

Although the study wasn't designed to prove cause and effect, the findings could point the way to new treatments for such diseases, according to the researchers.

"This is not the first study on the impact of hormone therapies on neurodegenerative disease reduction," study senior author Roberta Diaz Brinton, director of the University of Arizona Center for Innovation in Brain Science, said in a university news release. "But what is important about this study is that it advances the use of precision hormone therapies in the prevention of neurodegenerative disease, including Alzheimer's."

One expert not involved in the new trial was also cautiously optimistic.

"This study is important because it reconfirms the potential benefit of these hormonal therapies as a preventative means to improve brain health, rather than to treat a disease," said Dr. Jill Maura Rabin, an obstetrician-gynecologist at Northwell Health in New Hyde Park, N.Y.

The new analysis was funded by the Women's Alzheimer's Movement and the U.S. National Institute on Aging, and involved data from nearly 400,000 menopausal U.S. women, aged 45 and older. Their neurological health was tracked for an average of about five years.

The study found that women who had already received menopausal hormone therapy for six years or longer were 79% less likely to develop Alzheimer's and 77% less likely to develop any neurodegenerative disease over the term of follow-up.

The reduction of risk varied by type and route of hormone therapy and duration of use, according to the study published recently in the journal Alzheimer's & Dementia: Translational Research & Clinical Interventions.

For example, the use of the natural steroids estradiol or progesterone were associated with a greater risk reduction than the use of synthetic hormones, Brinton's group said. HRT taken in pill form was associated with a lower risk for combined neurodegenerative diseases, while hormone therapies administered through the skin reduced the risk of developing dementia.

Age seemed to matter, too: Overall risk was reduced the most in patients 65 or older, the study found.

The researchers also found hormone therapy that lasted longer than one year offered stronger protection against Alzheimer's, Parkinson's disease and dementia than therapy that lasted less than one year.

Neurodegenerative diseases associated with aging are a major public health concern in the United States.

"With this study, we are gaining mechanistic knowledge. This reduction in risk for Alzheimer's disease, Parkinson's and dementia means these diseases share a common driver regulated by estrogen, and if there are common drivers, there can be common therapies," Brinton said.

"The key is that hormone therapy is not a treatment, but it's keeping the brain and this whole system functioning, leading to prevention. It's not reversing disease; it's preventing disease by keeping the brain healthy," she explained.

Dr. Adi Katz directs gynecology at Lenox Hill Hospital in New York City. Reading over the findings, she said many women will intuitively understand the link between hormonal changes and brain function.

"Our hormones affect our brain and many women will tell you that they experience 'brain fog,' irritability, difficulty concentrating and forgetfulness during this time," Katz said. "'My brain is just not what it used to be,' is what we'll commonly hear."

According to Katz, "menopausal hormone replacement therapy is a safe option for healthy symptomatic women within 10 years of menopause. It helps with hot-flashes/night sweats, mood variability, depression, joint aches/pains and vaginal dryness. It decreases the rate of bone loss and cardiac disease."

But, like many experts, Katz stressed that HRT is not without its risks.

"The risk of the therapy includes increased risk of breast cancer and uterine cancer, stroke and blood clots," Katz noted.

Therefore, use of HRT "should be considered by women for its benefits as long as the risks are understood," she said. "A frank discussion with your gynecologist can help women make an informed decision."

Katz added that the study was retrospective, and only a prospective, randomized clinical trial could determine whether use of HRT directly lowers the odds for dementia and other neurological conditions in women.

For her part, Rabin said the study highlights the need for "individualized therapies, particularly when it comes to women and specifically in regard to pharmacologic therapies."

Because "women are not simply 'small men,' gender-based medicine is key in helping understand women's physiologies and responses to treatments," Rabin added.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.

SOURCES: Adi Katz, MD, director of gynecology, Lenox Hill Hospital, New York City; Jill Maura Rabin, MD, vice chair, education & development, obstetrician/gynecologist, Northwell Health, New Hyde Park, N.Y.; University of Arizona, news release, July 9, 2021




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net